Form 8-K - Current report:
SEC Accession No. 0001628280-24-047588
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:42
Documents
15
Period of Report
2024-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20241113.htm   iXBRL 8-K 29960
2 EX-99.1 zlab-20241113xex991_certai.htm EX-99.1 29909
  Complete submission text file 0001628280-24-047588.txt   234027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20241113.xsd EX-101.SCH 2151
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20241113_def.xml EX-101.DEF 15888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20241113_lab.xml EX-101.LAB 27758
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20241113_pre.xml EX-101.PRE 16626
17 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20241113_htm.xml XML 4062
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 241454068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)